ArticleAnnals of burns and fire disasters2025
[Gastro- Intestinal Complications in ICU Burn Patients].
Article in Annals of burns and fire disasters, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Gastrointestinal (GI) dysfunction in severely burned patients is common and serious. It results in disruption of the mucosal barrier, which is directly implicated in SIRS and enhanced endotoxin absorption and bacterial translocation that leads to MODS and death. We conducted a retrospective descriptive study in an intensive burn care department in Tunisia, over a period of 6 years, in order to evaluate the incidence of GI complications in burn patients and their impact on burn prognosis. A total of 54 patients were included. The mean age of our patients was 40 ± 22.5 years, with a sex-ratio of 1.25/1. In our series, 2 patients had a history of peptic ulcer and only one was on long-term corticosteroids. TBSA was 36.8 ± 16.1% and ABSI was 6.4 ± 2.8. Antiulcer prophylaxis was prescribed in patients with a history of ulcer (n=2). Systemic analgesia during dressing changes was prescribed in 88.9% of cases. The incidence of GI complications was 2.4%. The median delay of occurrence of these complications was 11.5 days. Revealing symptoms were: melena (n=12), hematemesis (n=11), and abdominal distension (n=11). Digestive hemorrhage was the most frequent (59.3%), followed by abdominal compartment syndrome (16.7%) and isolated peptic ulcer (11.1%). Treatment was medical in 87% of cases and surgery was required in 13% of cases. Mortality in our series was 66.7%.
Indexed as
Identifiers
41479631PMC12755342What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.